| scholarly article | Q13442814 |
| editorial | Q871232 |
| P356 | DOI | 10.18632/AGING.101134 |
| P8608 | Fatcat ID | release_hfxdehen6nbdtlebflyo2qr5em |
| P932 | PMC publication ID | 5191857 |
| P698 | PubMed publication ID | 27920406 |
| P2093 | author name string | Wolfgang Deppert | |
| Michael Bruns | |||
| P2860 | cites work | Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacy | Q28082914 |
| PD-1 Blockade in Tumors with Mismatch-Repair Deficiency | Q28262647 | ||
| Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis. | Q35817394 | ||
| An inducible transgenic mouse breast cancer model for the analysis of tumor antigen specific CD8+ T-cell responses | Q36629345 | ||
| T-cell epitope strength in WAP-T mouse mammary carcinomas is an important determinant in PD1/PD-L1 immune checkpoint blockade therapy. | Q37662081 | ||
| Transcription factors link mouse WAP-T mammary tumors with human breast cancer | Q39242906 | ||
| Low-grade and high-grade mammary carcinomas in WAP-T transgenic mice are independent entities distinguished by Met expression | Q39294303 | ||
| P433 | issue | 11 | |
| P921 | main subject | immunotherapy | Q1427096 |
| P304 | page(s) | 2607-2608 | |
| P577 | publication date | 2016-11-01 | |
| P1433 | published in | Aging | Q2845875 |
| P1476 | title | Cancer immunotherapy: weak beats strong | |
| P478 | volume | 8 |
Search more.